Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Stem Cell Therapy Industry?

In recent years, the market for stem cell therapy has seen swift expansion. Projected growth suggests it will increase from $7.86 billion in 2024 to $9.26 billion in 2025, representing a compound annual growth rate (CAGR) of 17.7%. Several factors have contributed to this growth over the historic period, including the increasing occurrence of chronic diseases, elevated funding from both government and private entities, a swift expansion in emerging markets, increased investment in cell and gene therapies, a spike in healthcare spending and a rise in research and development expenditure in the pharmaceutical sector.

The market for stem cell therapy is predicted to experience substantial expansion in the upcoming years, with projections suggesting it will reach “$14.6 billion by 2029, boasting a compound annual growth rate (CAGR) of 12.1%. This predicted surge in the forecast period can be traced back to the mounting support from governments, an increasing aging population, a rise in research and development expenses, and escalating healthcare expenditure. Significant market trends anticipated over the forecast period centre around careful tracking of progress in mesenchymal stem cell therapy with an aim to capitalise on innovations, companies in the sector are advised to partner with and buy out other businesses to propel product innovation and revenue growth. Additionally, it would be prudent for these companies to invest in developing ipsc-derived nk cells for patient treatment and to prioritize the development of stem cell therapies, particularly for cancer, to outpace their somatic cell competitors. Furthermore, leveraging artificial intelligence can significantly enhance product quality, safety, and boost manufacturing productivity in the stem cell therapy market.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

#Which Factors Are Currently Driving The Growth Of The Stem Cell Therapy Market?

The escalation in the incidence of chronic illnesses has aided the expansion of the stem cell therapy market. The prevalence of such diseases has been triggered by factors such as lengthy work schedules, minimal physical activity, and poor dietary and drinking habits, thereby enhancing the demand for stem cell therapy. A United Nations report anticipates that, by 2030, chronic diseases will account for 70% of total worldwide deaths. The global chronic disease burden is anticipated to hit around 60%. The growth in the prevalence of these chronic diseases is projected to fuel the growth of the stem cell therapy market.

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

What Upcoming Trends Are Expected To Impact The Stem Cell Therapy Market Globally?

Stem cell therapy market businesses are now more than ever indulging in strategic alliances. Such alliances essentially represent a win-win contract between two firms that don’t directly rival each other. This can be seen in an example from May 2022, where SQZ Biotechnologies, which originates from the US, entered into an alliance with Canadian company, STEMCELL Technologies Inc. Their common goal is to create and market a research-only microfluidic intracellular delivery system that leverages SQZ’s Cell Squeeze technology. This would provide the life science sector greater control in cell engineering for initial-stage research. The companies are set to reveal significant discoveries about the RUO system’s prowess in efficiently transferring goods to primary immune cell types and the progression they’ve made in cell engineering through mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Who Are The Main Participants Shaping The Stem Cell Therapy Market Landscape?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Which Region Currently Holds The Largest Share In The Stem Cell Therapy Market?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model